From serving at Ground Zero after September 11th to advancing patient-centered oncology care at Daiichi Sankyo, John Ruggiero shares how resilience, compassion, and purpose shaped his journey into the pharmaceutical industry. As Executive Director, U.S. Medical Affairs, HEOR, he reflects on cancer research, patient empowerment, and the culture that keeps him inspired.
For cancer patients, the science concerning their disease is sometimes outside of reach. As a patient-centric organization, we are on a mission to break down those barriers.
Cancer remains one of the most challenging diseases in the world today, but critical advances in science are transforming options for more personalized treatment.
A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.
As a teenager volunteering at a hospital, Simon King, Chief People Officer at Daiichi Sankyo, Inc., learned the difference between listening with his ears and listening with his heart.
Daiichi Sankyo supports “No One Missed” campaign to build awareness, empower patients and break down barriers to this essential step in cancer care.
As a champion of continuous learning, John Ruggiero, Ph.D., leverages the power of diverse voices to create better tomorrows for patients.